CorMedix Inc. (CRMD) |
|
4.5625 0.083 (1.84%)
|
02-03 14:42 |
|
Open: |
4.4 |
Pre. Close: |
4.48 |
|
High:
|
4.62 |
Low:
|
4.4 |
|
Volume:
|
195,443 |
Market Cap:
|
188(M) |
|
|
|
Technical analysis |
as of: 2023-02-03 2:15:54 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 5.53 One year: 6.46 |
| Support: |
Support1: 4.02 Support2: 3.58 |
| Resistance: |
Resistance1: 4.73 Resistance2: 5.53 |
| Pivot: |
4.37  |
| Moving Average: |
MA(5): 4.41 MA(20): 4.39
MA(100): 3.67 MA(250): 3.98 |
| MACD: |
MACD(12,26): 0 Signal(9): 0  |
| Stochastic oscillator: |
%K(14,3): 74.9 %D(3): 65.1 |
| RSI: |
RSI(14): 59.7 |
| 52-week: |
High: 8.02 Low: 2.65 |
| Average Vol(K): |
3-Month: 251 (K) 10-Days: 239 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CRMD ] has closed below upper band by 21.1%. Bollinger Bands are 37% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.65 - 4.66 |
4.66 - 4.68 |
|
Low:
|
4.36 - 4.39 |
4.39 - 4.41 |
|
Close:
|
4.45 - 4.48 |
4.48 - 4.51 |
|
Company Description |
|
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. |
Headline News |
Thu, 02 Feb 2023
Daraz appoints Talat Rahim as chief marketing officer - The Business Standard
Thu, 02 Feb 2023
Mercantile Bank holds CIB Online Reporting training - The Business Standard
Sat, 21 Jan 2023
How to Set Up a Company in Cyprus: The Ultimate Guide - Nomad Capitalist
Tue, 17 Jan 2023
CorMedix Inc. Announces Promotions in Commercial and Tech Ops - GlobeNewswire
Thu, 12 Jan 2023
ERE Healthcare Real Estate Advisors ('ERE') is Pleased to Announce the Successful Sale of a 34,090 SF Comprehensive Retina and Dialysis Portfolio in Central Florida - Yahoo Finance
Wed, 16 Nov 2022
Will CorMedix Inc. (CRMD) Outperform the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
0 (M) |
| Shares Float |
41 (M) |
|
% Held by Insiders
|
4.073e+007 (%) |
|
% Held by Institutions
|
1.2 (%) |
|
Shares Short
|
1,540 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-2.993e+007 |
|
EPS Est Next Qtl
|
-0.13 |
|
EPS Est This Year
|
-0.53 |
|
EPS Est Next Year
|
-0.29 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-32 |
|
Return on Assets (ttm)
|
588.1 |
|
Return on Equity (ttm)
|
-27.3 |
|
Qtrly Rev. Growth
|
92100 |
|
Gross Profit (p.s.)
|
-34.94 |
|
Sales Per Share
|
-19.84 |
|
EBITDA (p.s.)
|
17872.3 |
|
Qtrly Earnings Growth
|
-0.8 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-24 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
-0.23 |
|
Price to Cash Flow
|
7.75 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
1.64e+006 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2019-03-25 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
